Platelet-Activating Factor (PAF) Receptors

16 Items

per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Product Citation
  1. PAFR antagonist

    Ginkgolide B (BN 52021) is a PAFR antagonist with IC50 of 3.6 μM.
  2. PAFR inhibitor/H1 receptor inhibitor

    Rupatadine is an inhibitor of PAFR and histamine (H1) receptor with Ki of 550 and 102 nM, respectively.
  3. PAF antagonist

    Aglafoline is an effective PAF antagonist not only in vitro, but also in vivo.
  4. PAF antagonist

    48740 RP (RP-55778) is a platelet-activating factor (PAF) antagonist.
  5. PAFR inhibitor/H1 receptor inhibitor

    Rupatadine is an inhibitor of PAFR and histamine (H1) receptor with Ki of 550 and 102 nM, respectively.
  6. LTD4/PAF receptor antagonist

    CP-96486 is a potent and orally active leukotriene D4 (LTD4)/platelet activating factor (PAF) receptor antagonist with Kis of 20 and 24 nM, respectively.
  7. PAF receptor antagonist

    Foropafant (SR27417) highly potent, competitive, selective and orally active antagonist of platelet-activating factor (PAF) receptor.
  8. PAFR antagonist

    Etizolam is a specific platelet-activating factor (PAF) antagonist with anti-anxiety activity.
  9. PAF antagonist

    Tulopafant is a platelet activating factor (PAF) antagonist.
  10. PAF antagonist

    Apafant (WEB 2086), a potent platelet-activating factor (PAF) antagonist, inhibits PAF binding to human PAF receptors with a Ki of 9.9 nM.
  11. PAF antagonist

    Setipafant is a platelet-activating factor (PAF) antagonist.
  12. PAF antagonist

    YM-264 is a selective, potent and orally active platelet-activating factor (PAF) antagonist with a pKi value of 8.85 for rabbit platelet membranes.
  13. PAF antagonist

    Ro 24-4736 is a potent, selective, p.o.-active platelet-activating factor (PAF) antagonist with a long duration of action.
  14. thromboxane synthesis inhibitor

    Ro-24-0238 is an antagonist of platelet activating factor (PAF) and inhibitor of thromboxane synthesis, used for lessening the inflammation and damage resulting from a local release of PAF.
  15. antiplatelet activities

    6-Methoxydihydroavicine is an alkaloid isolated from Zanthoxylum integrifoliolum. 6-Methoxydihydroavicine has antiplatelet activities and inhibits AA-, collagen- and PAF-induced platelet aggregation in vitro.

16 Items

per page
Set Descending Direction